March is National Kidney Month, and RTI-HS joins patient advocacy groups and the medical, research, and pharmaceutical industries in raising awareness for kidney health.
1 in 3 American adults are at risk for developing kidney disease, underscoring the continued need for expert research to support the development of and access to pharmaceutical and medical products to benefit these patients.
Read more about our research. Combined, we have over 200 publications in these areas:
Our team includes experts such as James Rosenzweig, M.D., Senior Director of Clinical Consulting. Dr. Rosenzweig led and co-created endocrine disease management guidelines on a national level. He chaired the working group that published Clinical Practice Guideline for Primary Prevention of Cardiovascular Disease and Type 2 Diabetes in Patients at Metabolic Risk in 2008 for the Endocrine Society and is now chairing the working group to revise and update these guidelines. He was also an author of the consensus document Hypoglycemia and Diabetes: A report of the Workgroup of the American Diabetes Association and The Endocrine Society.
In addition to Dr. Rosenzweig, we have a 40+ person team with expertise in Diabetes & Endocrine Disorders and Nephrology across multiple areas: